搜索
ATAI Life Sciences NV
ATAI添加自选
7.180USD
0.0000.00%
收盘 07-31 16:00（美东）报价延迟15分钟
2.66B总市值
亏损市盈率 TTM
关于 ATAI Life Sciences NV 公司
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NV简介
公司代码ATAI
公司名称ATAI Life Sciences NV
上市日期Jun 18, 2021
CEORao (Srinivas G)
员工数量54
证券类型Ordinary Share
年结日Jun 18
公司地址Prof. J.H.Bavincklaan 7
城市AMSTELVEEN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Netherlands
邮编1183 AT
电话31207932536
网址https://www.atai.com/
公司代码ATAI
上市日期Jun 18, 2021
CEORao (Srinivas G)
ATAI Life Sciences NV公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
常见问题
ATAI Life Sciences NV的前五大股东是谁？
ATAI Life Sciences NV 的前五大股东如下：Dr. Glenn Frank Short, Ph.D.
有多少机构持有ATAI Life Sciences NV(ATAI)的股份？
截至2026Q1，共有296家机构持有ATAI Life Sciences NV的股份，合计持有的股份价值约为73.07M，占公司总股份的19.93%。与2025Q4相比，机构持股有所增加，增幅为23428346.00。